Cost-effectiveness Analysis of Genetic Testing and Tailored First-Line Therapy for Patients With Metastatic Gastrointestinal Stromal Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost-effectiveness Analysis of Genetic Testing and Tailored First-Line Therapy for Patients With Metastatic Gastrointestinal Stromal Tumors

Published:2020-09-28 Issue:9 Volume:3 Page:e2013565
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Banerjee Sudeep¹²,Kumar Abhishek³,Lopez Nicole⁴,Zhao Beiqun¹,Tang Chih-Min¹,Yebra Mayra¹,Yoon Hyunho¹,Murphy James D.³,Sicklick Jason K.¹

Affiliation:

1. Department of Surgery, Division of Surgical Oncology, University of California, San Diego

2. Department of Surgery, University of California, Los Angeles

3. Department of Radiation Medicine and Applied Sciences, University of California, San Diego

4. Department of Surgery, Division of Colorectal Surgery, University of California, San Diego

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2770875/banerjee_2020_oi_200512_1600201485.24741.pdf

Reference43 articles.

1. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.;Demetri;N Engl J Med,2002

2. Gastrointestinal stromal tumours: origin and molecular oncology.;Corless;Nat Rev Cancer,2011

3. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial.;Demetri;Lancet,2006

4. Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.;Demetri;Lancet,2013

5. Gastrointestinal stromal tumors.;Liegl-Atzwanger;Virchows Arch,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness and the Economics of Genomic Testing and Molecularly Matched Therapies;Surgical Oncology Clinics of North America;2024-04

2. Assessing the Utility of Measurement Methods Applied in Economic Evaluations of Pharmacogenomics Applications;Pharmacogenomics;2024-01

3. Cost Evaluation Analysis of Genetic Testing and Tailored Adjuvant Imatinib in Patients With Resected High-Risk GI Stromal Tumors: The Brazilian Perspective;JCO Global Oncology;2023-09

4. Consensus Statements on Precision Oncology in the China Greater Bay Area;JCO Precision Oncology;2023-06

5. Comprehensive Review on the Clinical Impact of Next-Generation Sequencing Tests for the Management of Advanced Cancer;JCO Precision Oncology;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3